But we can not say in advance how
much benefit genomes at birth would provide, nor can we predict how much anxiety they would create in children or their parents.
Rapidly evolving approaches to the comprehensive profiling of patients» risk factors, such as whole -
genome sequencing, will play an increasingly important role in overcoming neurological disease, in
much the same way as these approaches are already used to match up certain cancer patients with specific drugs they stand to
benefit from the most.